Tumor suppressor p53 and its mutants in cancer metabolism

被引:200
|
作者
Liu, Juan [1 ]
Zhang, Cen [1 ]
Hu, Wenwei [1 ,2 ]
Feng, Zhaohui [1 ]
机构
[1] Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ 08903 USA
[2] Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Pediat, New Brunswick, NJ 08903 USA
关键词
Tumor suppressor; p53; Mutant p53; Metabolism; LI-FRAUMENI-SYNDROME; FATTY-ACID SYNTHESIS; GLUCOSE-METABOLISM; LIPID-METABOLISM; P53-INDUCIBLE REGULATOR; MEVALONATE PATHWAY; ENERGY-METABOLISM; CELL-METABOLISM; GENE-EXPRESSION; TARGET GENE;
D O I
10.1016/j.canlet.2013.12.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-suppressor p53 plays a key role in tumor prevention. As a transcription factor, p53 transcriptionally regulates its target genes to initiate different biological processes in response to stress, including apoptosis, cell cycle arrest or senescence, to exert its function in tumor suppression. Recent studies have revealed that metabolic regulation is a novel function of p53. Metabolic changes have been regarded as a hallmark of tumors and a key contributor to tumor development. p53 regulates many different aspects of metabolism, including glycolysis, mitochondrial oxidative phosphorylation, pentose phosphate pathway, fatty acid synthesis and oxidation, to maintain the homeostasis of cellular metabolism, which contributes to the role of p53 in tumor suppression. p53 is frequently mutated in human tumors. In addition to loss of tumor suppressive function, tumor-associated mutant p53 proteins often gain new tumorigenic activities, termed gain-of-function of mutant p53. Recent studies have shown that mutant p53 mediates metabolic changes in tumors as a novel gain-of-function to promote tumor development Here we review the functions and mechanisms of wild-type and mutant p53 in metabolic regulation, and discuss their potential roles in tumorigenesis. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [31] Manipulation of the tumor suppressor p53 for potentiating cancer therapy
    Haupt, S
    Haupt, Y
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (04) : 244 - 252
  • [32] APOPTOSIS, CANCER AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    BERNSTEIN, A
    [J]. CANCER AND METASTASIS REVIEWS, 1995, 14 (02) : 149 - 161
  • [33] Alterations in p53 tumor suppressor gene in lung cancer
    Zalcman, G
    Soussi, T
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (01) : 329 - 349
  • [34] p53: The Attractive Tumor Suppressor in the Cancer Research Field
    Ozaki, Toshinori
    Nakagawara, Akira
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [35] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    [J]. CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [36] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    Loging, WT
    Reisman, D
    [J]. ONCOGENE, 1999, 18 (52) : 7608 - 7615
  • [37] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    W Troy Loging
    David Reisman
    [J]. Oncogene, 1999, 18 : 7608 - 7615
  • [38] disrupting binding of p53 mutants to PEPD unleashes their tumor suppressor activities.
    Yang, Lu
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [39] Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
    Bernal, Federico
    Tyler, Andrew F.
    Korsmeyer, Stanley J.
    Walensky, Loren D.
    Verdine, Gregory L.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) : 2456 - +
  • [40] Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
    Bernal, Federico
    Tyler, Andrew F.
    Korsmeyer, Stanley J.
    Walensky, Loren D.
    Verdine, Gregory L.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (16) : 5298 - 5298